MEETINGS - Conference on Clinical Trials Design (US) February 2003:
This article was originally published in Clinica
Thec Clinical Device Group is hosting a conference on Clinical Trials Design on February 3-4 2003 at the Radisson Hotel, San Diego, California. This seminar is designed to teach delegates the principles behind designing a clinical trial. All delegates will receive a copy of the book Clinical Trials Design. Further details on tel: +1 773 489 5706; fax: +1 773 489 5982; email: cdginc@ clinicaldevice.com www. clinicaldevice.com
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.